<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18" class="ref">
 <label class="label">18.</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Hicks</surname>
    <given-names class="given-names">A</given-names>
   </name>
   <name class="name">
    <surname class="surname">Monkarsh</surname>
    <given-names class="given-names">SP</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hoffman</surname>
    <given-names class="given-names">AF</given-names>
   </name>
   <name class="name">
    <surname class="surname">Goodnow</surname>
    <given-names class="given-names">R</given-names>
    <suffix class="suffix">Jr</suffix>
   </name>
  </person-group>. 
  <article-title class="article-title">Leukotriene B
   <sub class="sub">4</sub> receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments
  </article-title>. 
  <source class="source">Expert Opin Investig Drugs.</source> (
  <year class="year">2007</year>) 
  <volume class="volume">16</volume>:
  <fpage class="fpage">1909</fpage>â€“
  <lpage class="lpage">20</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1517/13543784.16.12.1909</pub-id>
  <?supplied-pmid 18042000?>
  <pub-id pub-id-type="pmid" class="pub-id">18042000</pub-id>
 </mixed-citation>
</ref>
